DAFNA Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Hold
371,434
0.3% 55
2025
Q1
$799K Hold
371,434
0.23% 65
2024
Q4
$1.44M Sell
371,434
-122,840
-25% -$475K 0.37% 48
2024
Q3
$3.24M Sell
494,274
-145,700
-23% -$954K 0.76% 32
2024
Q2
$4.64M Sell
639,974
-16,399
-2% -$119K 1.11% 25
2024
Q1
$4.98M Buy
656,373
+332,500
+103% +$2.52M 1.13% 27
2023
Q4
$1.47M Sell
323,873
-3,500
-1% -$15.9K 0.35% 51
2023
Q3
$1.29M Sell
327,373
-23,000
-7% -$90.9K 0.4% 47
2023
Q2
$1.1M Buy
350,373
+113,500
+48% +$355K 0.3% 51
2023
Q1
$1.07M Sell
236,873
-236,263
-50% -$1.07M 0.32% 45
2022
Q4
$1.95M Sell
473,136
-101,860
-18% -$421K 0.55% 46
2022
Q3
$1.84M Buy
574,996
+525,000
+1,050% +$1.68M 0.49% 43
2022
Q2
$98K Hold
49,996
0.03% 90
2022
Q1
$202K Sell
49,996
-20,181
-29% -$81.5K 0.05% 91
2021
Q4
$757K Buy
70,177
+5,690
+9% +$61.4K 0.19% 72
2021
Q3
$744K Sell
64,487
-12,500
-16% -$144K 0.2% 72
2021
Q2
$756K Sell
76,987
-4,445
-5% -$43.6K 0.16% 76
2021
Q1
$1.19M Buy
81,432
+33,004
+68% +$482K 0.28% 70
2020
Q4
$1.04M Sell
48,428
-30,727
-39% -$658K 0.31% 59
2020
Q3
$1.2M Sell
79,155
-47,106
-37% -$715K 0.39% 51
2020
Q2
$1.62M Buy
126,261
+100,803
+396% +$1.29M 0.47% 44
2020
Q1
$235K Hold
25,458
0.1% 76
2019
Q4
$339K Hold
25,458
0.12% 74
2019
Q3
$226K Buy
25,458
+1,666
+7% +$14.8K 0.09% 81
2019
Q2
$340K Sell
23,792
-3,875
-14% -$55.4K 0.13% 77
2019
Q1
$910K Buy
27,667
+21,644
+359% +$712K 0.39% 53
2018
Q4
$358K Sell
6,023
-1,131
-16% -$67.2K 0.18% 63
2018
Q3
$1M Sell
7,154
-6,461
-47% -$906K 0.41% 52
2018
Q2
$1.67M Buy
+13,615
New +$1.67M 0.78% 36